Zebra Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Zebra Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61,984	Closed	-$222K	–	190
2021 Q4	$222K	Sell	61,984 -10,381	-14%	-$36.3K	0.36%	110
2021 Q3	$264K	Buy	72,365 +43,927	+154%	+$178K	0.32%	116
2021 Q2	$124K	Hold	28,438	–	–	0.15%	147
2021 Q1	$117K	Sell	28,438 -115,888	-80%	-$502K	0.13%	159
2020 Q4	$576K	Sell	144,326 -7,403	-5%	-$23.9K	0.73%	54
2020 Q3	$409K	Buy	151,729 +81,717	+117%	+$226K	0.63%	66
2020 Q2	$193K	Sell	70,012 -14,951	-18%	-$41.7K	0.28%	164
2020 Q1	$200K	Buy	84,963 +1,395	+2%	+$4.75K	0.32%	142
2019 Q4	$392K	Buy	+83,568	New	+$342K	0.35%	115

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Zebra Capital Management's ATRS Position: Q1 2022 in Review

Zebra Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2022, closing a stake of 61,984 shares — an estimated $222K sold.

Zebra Capital Management first reported a position in ATRS in Q4 2019 and held it in 9 quarters. The position peaked at $576K in Q4 2020. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

Zebra Capital Management reported no remaining Antares Pharma, Inc. position as of Q1 2022 after selling out during the quarter.
Zebra Capital Management sold 61,984 Antares Pharma, Inc. shares in Q1 2022, an estimated $222K.
Zebra Capital Management first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 9 quarters.
Zebra Capital Management's Antares Pharma, Inc. position peaked at $576K in Q4 2020.
177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.